Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NUVB |
---|---|---|
09:32 ET | 102076 | 2.76 |
09:34 ET | 1600 | 2.73 |
09:36 ET | 7474 | 2.7192 |
09:38 ET | 1142 | 2.71 |
09:39 ET | 200 | 2.705 |
09:41 ET | 2907 | 2.69 |
09:43 ET | 602 | 2.69 |
09:45 ET | 19944 | 2.675 |
09:48 ET | 1714 | 2.67 |
09:50 ET | 13959 | 2.655 |
09:52 ET | 12068 | 2.66 |
09:54 ET | 20074 | 2.645 |
09:56 ET | 1292 | 2.64 |
09:57 ET | 1100 | 2.64 |
09:59 ET | 27203 | 2.645 |
10:01 ET | 8209 | 2.6374 |
10:03 ET | 8556 | 2.64 |
10:06 ET | 6696 | 2.64 |
10:08 ET | 3204 | 2.635 |
10:10 ET | 19098 | 2.6598 |
10:12 ET | 1100 | 2.665 |
10:14 ET | 200 | 2.665 |
10:15 ET | 12579 | 2.655 |
10:17 ET | 500 | 2.659 |
10:19 ET | 3832 | 2.655 |
10:21 ET | 400 | 2.66 |
10:24 ET | 4767 | 2.65 |
10:26 ET | 19184 | 2.645 |
10:28 ET | 950 | 2.64 |
10:30 ET | 2400 | 2.645 |
10:32 ET | 1400 | 2.64 |
10:33 ET | 6186 | 2.65 |
10:35 ET | 2140 | 2.64 |
10:37 ET | 9518 | 2.65 |
10:39 ET | 13019 | 2.67 |
10:42 ET | 1300 | 2.66 |
10:44 ET | 8295 | 2.67 |
10:46 ET | 500 | 2.67 |
10:48 ET | 27145 | 2.68 |
10:50 ET | 1670 | 2.6797 |
10:51 ET | 200 | 2.675 |
10:53 ET | 8979 | 2.68 |
10:55 ET | 300 | 2.67 |
10:57 ET | 16118 | 2.68 |
11:00 ET | 25819 | 2.675 |
11:02 ET | 4755 | 2.665 |
11:04 ET | 1885 | 2.655 |
11:06 ET | 800 | 2.655 |
11:08 ET | 520 | 2.6594 |
11:09 ET | 1762 | 2.665 |
11:11 ET | 3568 | 2.67 |
11:13 ET | 200 | 2.67 |
11:15 ET | 1934 | 2.675 |
11:18 ET | 775 | 2.675 |
11:20 ET | 1007 | 2.675 |
11:24 ET | 338 | 2.67 |
11:26 ET | 2057 | 2.6785 |
11:27 ET | 31758 | 2.66 |
11:29 ET | 1350 | 2.67 |
11:31 ET | 698 | 2.675 |
11:33 ET | 5384 | 2.68 |
11:36 ET | 7291 | 2.68 |
11:38 ET | 100 | 2.69 |
11:40 ET | 2100 | 2.69 |
11:42 ET | 14992 | 2.705 |
11:44 ET | 10200 | 2.7 |
11:45 ET | 11624 | 2.71 |
11:49 ET | 100 | 2.705 |
11:51 ET | 11701 | 2.7 |
11:54 ET | 5935 | 2.71 |
11:56 ET | 1000 | 2.715 |
11:58 ET | 6382 | 2.71 |
12:00 ET | 4618 | 2.705 |
12:02 ET | 149 | 2.705 |
12:03 ET | 10000 | 2.7001 |
12:05 ET | 13082 | 2.7 |
12:07 ET | 5043 | 2.73 |
12:09 ET | 10750 | 2.72 |
12:12 ET | 1650 | 2.715 |
12:14 ET | 10500 | 2.71 |
12:16 ET | 1334 | 2.72 |
12:18 ET | 7550 | 2.705 |
12:20 ET | 22510 | 2.72 |
12:21 ET | 3378 | 2.73 |
12:23 ET | 705 | 2.735 |
12:25 ET | 500 | 2.73 |
12:27 ET | 17791 | 2.72 |
12:30 ET | 400 | 2.73 |
12:36 ET | 2591 | 2.73 |
12:38 ET | 5417 | 2.7201 |
12:43 ET | 200 | 2.725 |
12:45 ET | 12560 | 2.725 |
12:48 ET | 21474 | 2.725 |
12:50 ET | 100 | 2.725 |
12:54 ET | 5696 | 2.73 |
12:56 ET | 200 | 2.73 |
12:57 ET | 100 | 2.725 |
12:59 ET | 300 | 2.725 |
01:01 ET | 300 | 2.725 |
01:03 ET | 4742 | 2.725 |
01:06 ET | 3630 | 2.73 |
01:08 ET | 10208 | 2.725 |
01:10 ET | 2037 | 2.725 |
01:12 ET | 14399 | 2.7298 |
01:14 ET | 300 | 2.73 |
01:15 ET | 12236 | 2.715 |
01:17 ET | 100 | 2.72 |
01:19 ET | 100 | 2.715 |
01:21 ET | 13050 | 2.715 |
01:24 ET | 1987 | 2.71 |
01:26 ET | 500 | 2.71 |
01:28 ET | 7444 | 2.705 |
01:30 ET | 700 | 2.705 |
01:32 ET | 727 | 2.705 |
01:33 ET | 48159 | 2.69 |
01:35 ET | 100 | 2.695 |
01:37 ET | 7838 | 2.695 |
01:42 ET | 200 | 2.695 |
01:44 ET | 10549 | 2.685 |
01:46 ET | 666 | 2.6848 |
01:48 ET | 308 | 2.69 |
01:50 ET | 15204 | 2.69 |
01:51 ET | 1900 | 2.69 |
01:53 ET | 9009 | 2.695 |
01:55 ET | 1722 | 2.7 |
01:57 ET | 100 | 2.7 |
02:00 ET | 610 | 2.695 |
02:02 ET | 1550 | 2.695 |
02:04 ET | 1308 | 2.7 |
02:08 ET | 7580 | 2.7 |
02:09 ET | 200 | 2.7 |
02:11 ET | 200 | 2.7 |
02:13 ET | 300 | 2.7 |
02:15 ET | 885 | 2.6901 |
02:18 ET | 21691 | 2.68 |
02:20 ET | 8492 | 2.675 |
02:22 ET | 53254 | 2.66 |
02:24 ET | 1200 | 2.66 |
02:26 ET | 975 | 2.655 |
02:27 ET | 972 | 2.655 |
02:29 ET | 9709 | 2.655 |
02:31 ET | 6480 | 2.67 |
02:33 ET | 7933 | 2.67 |
02:36 ET | 660 | 2.6601 |
02:38 ET | 19181 | 2.7 |
02:40 ET | 630 | 2.7 |
02:42 ET | 300 | 2.7 |
02:44 ET | 300 | 2.7 |
02:45 ET | 3647 | 2.695 |
02:47 ET | 2238 | 2.695 |
02:49 ET | 1982 | 2.695 |
02:51 ET | 9460 | 2.68 |
02:54 ET | 218 | 2.675 |
02:56 ET | 1505 | 2.68 |
02:58 ET | 1076 | 2.68 |
03:00 ET | 1992 | 2.675 |
03:02 ET | 782 | 2.68 |
03:03 ET | 16295 | 2.68 |
03:05 ET | 2608 | 2.685 |
03:07 ET | 300 | 2.685 |
03:09 ET | 6764 | 2.675 |
03:12 ET | 7995 | 2.67 |
03:14 ET | 800 | 2.67 |
03:16 ET | 954 | 2.665 |
03:18 ET | 757 | 2.67 |
03:20 ET | 400 | 2.67 |
03:21 ET | 28876 | 2.655 |
03:23 ET | 5459 | 2.665 |
03:25 ET | 600 | 2.665 |
03:27 ET | 870 | 2.665 |
03:30 ET | 363 | 2.67 |
03:32 ET | 14019 | 2.665 |
03:34 ET | 1300 | 2.665 |
03:36 ET | 3781 | 2.66 |
03:38 ET | 1068 | 2.66 |
03:39 ET | 4101 | 2.665 |
03:41 ET | 500 | 2.66 |
03:43 ET | 109 | 2.6699 |
03:45 ET | 1450 | 2.66 |
03:48 ET | 18247 | 2.655 |
03:50 ET | 2365 | 2.655 |
03:52 ET | 6958 | 2.665 |
03:54 ET | 3824 | 2.665 |
03:56 ET | 1398 | 2.665 |
03:57 ET | 7650 | 2.665 |
03:59 ET | 261317 | 2.66 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Nuvation Bio Inc | 917.3M | -1.3x | --- |
Sana Biotechnology Inc | 909.9M | -3.6x | --- |
CARGO Therapeutics Inc | 894.2M | -5.6x | --- |
Autolus Therapeutics PLC | 931.3M | -3.0x | --- |
IGM Biosciences Inc | 948.5M | -4.6x | --- |
Cullinan Therapeutics Inc | 964.2M | -5.7x | --- |
Nuvation Bio Inc. is a biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. The Company is advancing multiple clinical-stage candidates, including a ROS1 inhibitor, a mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor, a bromodomain and extra-terminal (BET) inhibitor, and a drug-drug conjugate (DDC). Its portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Taletrectinib is an oral, potent, CNS-active, selective, ROS1 inhibitor specifically designed for the potential treatment of ROS1-positive non-small cell lung cancer (NSCLC). Safusidenib is an oral, potent, targeted inhibitor of mIDH1 being evaluated in a global Phase II trial in patients with low-grade IDH1-mutant glioma. NUV-868 is a BD2-selective oral small molecule BET inhibitor, that inhibits BRD4. It is conducting Phase I/II study of NUV-1511.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $917.3M |
---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 334.8M |
Nuvation Bio Inc does not pay a dividend. | |
Beta | 1.38 |
EPS | $-2.11 |
Book Value | $2.76 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 639.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -37,474.14% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.